UFPT UFP TECHNOLOGIES INC
Price Chart
Executive Summary
UFP Technologies reported record 2025 results with revenue of $602.8 million (up 19.5% YoY) and net income of $68.3 million (up 15.8% YoY). Full-year GAAP EPS was $8.75, up from $7.58 in 2024. The growth was driven by a 23.2% increase in medical sales, partially offset by an 11.5% decline in non-medical sales. Despite $6.3 million in labor-related inefficiencies at its Illinois facility, the company delivered strong profitability and raised its long-term outlook due to strategic expansions in the Dominican Republic and successful integration of recent acquisitions.
Key Financial Metrics
Actionable Insight
The company's strong medical segment growth, successful acquisition integrations, and operational improvements in the Dominican Republic suggest sustained momentum. Traders should monitor Q1 2026 for margin recovery as labor inefficiencies at the Illinois facility continue to resolve. The bullish guidance and robust pipeline indicate potential for upward revisions to earnings estimates.
Key Facts
- 2025 net sales: $602.8 million (+19.5% YoY)
- 2025 net income: $68.3 million (+15.8% YoY)
- 2025 GAAP EPS: $8.75 (+15.4% YoY)
- Medical sales grew 23.2% to $555.3 million
- Non-medical sales declined 11.5% to $47.5 million
- $6.3 million in labor-related costs at AJR facility in Illinois, mostly resolved by Q4
- Expanded operations in Dominican Republic with new facilities and customer contract extensions
- Completed 7 acquisitions in 2024 and 2025, all integrating well
Financial Impact
Revenue up 19.5% to $602.8M, net income up 15.8% to $68.3M, EPS up 15.4% to $8.75
Segment Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Medical | $555.3M | +23.2% |
| Non-Medical | $47.5M | -11.5% |
Risk Factors
- Labor inefficiencies at Illinois facility could persist longer than expected
- Concentration risk with two largest customers accounting for substantial revenue
- Integration risks from recent acquisitions
- Cybersecurity incident disclosed in the same filing could lead to operational or financial disruption
Market Snapshot
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001628280-26-011150 |
| Document: ufpt-20260224.htm | 0001628280-26-011150 |
| Document: 0001628280-26-011150-index-headers.html | 0001628280-26-011150 |
| Document: 0001628280-26-011150-index.html | 0001628280-26-011150 |
| Document: 0001628280-26-011150.txt | 0001628280-26-011150 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 8, 2026
1d ago
|
8-K
| $226.58 awaiting T+5 | awaiting T+5 | — | $226.71 (+0.06%) |
|
May 26, 2026
14d ago
|
8-K
| $226.37 $218.34 | ▼ −3.55% | ▼ −4.02% | $226.71 (+0.15%) |
|
May 4, 2026
5w ago
|
8-K
| $212.43 $220.59 | ▲ +3.84% | ▲ +1.86% | $226.71 (+6.72%) |
|
Apr 30, 2026
5w ago
|
Press Release
| $191.63 $218.20 | ▼ −13.87% | ▼ −12.14% | $226.71 (−18.31%) |
|
Mar 17, 2026
12w ago
|
Press Release
| $205.65 $189.57 | ▼ −7.82% | ▼ −5.16% | $226.71 (+10.24%) |
|
Feb 24, 2026
15w ago
|
8-K
| $240.16 $203.99 | ▼ −15.06% | ▼ −13.96% | $226.71 (−5.60%) |
|
Feb 24, 2026
15w ago
|
8-K
| $240.16 $203.99 | ▲ +15.06% | ▲ +13.96% | $226.71 (+5.60%) |
|
Feb 24, 2026
15w ago
|
8-K
| $240.16 $203.99 | ▼ −15.06% | ▼ −13.96% | $226.71 (−5.60%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access